SymbolCFRXQ
NameCONTRAFECT CORPORATION
SectorUNDEFINED
RegionNorth America
Industry-
Address10701 United States NY 28 Wells Avenue 3rd Floor
Telephone(914) 207-2300
Fax
Email
Websitehttps://www.contrafect.com/
IncorporationUS
Incorporated On
Employees
Fiscal Year12/31
Public Since
ExchangesOTC
Auditor
Audit StatusAUDITED
Reporting StatusU.S. Reporting: SEC Reporting
CIK0001478069
Description

ContraFect is a clinical-stage biotechnology company focused on discovering and developing biologic therapies for life-threatening, drug-resistant infectious diseases, particularly those treated in hospital settings.

Additional info from OTC:
ContraFect is a clinical-stage biotechnology company focused on discovering and developing biologic therapies for life-threatening, drug-resistant infectious diseases, particularly those treated in hospital settings.

2025-04-28 20:00

New Form SEC STAFF ACTION - CONTRAFECT Corp Filed: 2025-04-28 AccNo: 9999999997-25-002090 Size: 3 KB

Read more
2024-08-28 03:13

Expert Market symbol attribute type Security_Name was changed. Previous value: -. New value: CONTRAFECT CORP.

Read more
2024-08-27 08:15

OTCQX U.S. Premier symbol attribute type Security_Name was changed. Previous value: CONSUMERS BANCORP INC. New value: CONTRAFECT CORP.

Read more
2024-04-26 03:53

Pink Limited symbol attribute type Security_Name was changed. Previous value: -. New value: CONTRAFECT CORP.

Read more
2024-02-14 19:24

New Form SC 13G/A - CONTRAFECT Corp Filed: 2024-02-14 AccNo: 0001172661-24-001220 Size: 90 KB

Read more